Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Executive Overview and Outlook
ZBH logo

Zimmer Biomet's Q2 Sales Rise 7% to $2.1B Despite Earnings Drop from Acquisitions

ZBH10-QFiling Date: 8/7/2025
Zimmer Biomet Holdings, Inc.
Description

What this story covers

Zimmer Biomet reported Q2 net sales of $2.1 billion, up 7% YoY, driven by Paragon 28 acquisition and organic growth in orthopedics. However, net earnings fell to $153 million due to integration costs, inflation, and higher debt interest. Full-year sales outlook: 6.7-7.7% growth; earnings expected lower amid tariffs and taxes. Strong liquidity supports ongoing strategies.

Story snapshot

CompanyZimmer Biomet Holdings, Inc.
TickerZBH
VariantStandard detailed
Duration13:04
Filing type10-Q
PeriodQ2 2025
IndustryHealthcare & Pharmaceuticals
Accession0000950170-25-104989

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in